Limit: 1 // Tickets Available: 0
E. Hamden (Space Institute)
Limiting Language
Limit: 1 // Tickets Available: 0
M. Beidaghi (Aerospace and Mechanical Engineering)
Limiting Language
An institution may submit only a single proposal in response to this solicitation, as the lead institution.
If more than one proposal is submitted from an institution, the first proposal submitted from that institution will be considered, and remaining proposals will be returned without review.
No Applicants // Limit: 1 // Tickets Available: 1
Limiting Language
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding.
Executive Summary
Priority Region: Jordan
U of A Center for Biomedical Informatics and Biostatistics (CB2)
No Applicants // Limit: 1 // Tickets Available: 1
Limiting Language
No Applicants // Limit: 1 // Tickets Available: 1
Limiting Language
Applicants are only allowed to submit one proposal per organization. If more than one proposal is submitted from an organization, all proposals from that institution will be considered ineligible for funding.
Executive Summary
Priority Region: Jordan
Dear colleagues,
I am pleased to announce the appointment of Dr. Krishna Muralidharan as Director of the Center for Semiconductor Manufacturing. After serving effectively as interim director, Dr. Muralidharan has already set a strong foundation for CSM’s continued growth and relevance in one of our nation’s most strategically important industries.
The Comprehensive Center for Pain and Addiction addresses chronic pain and substance use disorders by combining research, clinical care, education, policy and technology to expand access to nonopioid treatments, advance clinical trials and engage communities.
The Center for Sleep and Circadian Sciences studies how sleep and biological rhythms affect health and disease, using controlled human studies and imaging to inform interventions that range from gene-level discovery to public safety.
CIBS drives therapeutic development for Alzheimer’s, Parkinson’s, Multiple Sclerosis and ALS by linking basic discovery to clinical application through precision medicine, data science and patient-centered research.